Anti-Malaria Treatment ArTiMist Enters Production
Filed with ASX ·
6ix hasn’t read this filing yet.
Arovella Therapeutics Limited on 6ix
Earlier from Arovella Therapeutics
- Successful completion of phase 1 multi-dose study
- Eastland ArTiMist Update
- Financial Update and Refund Of Rights Issue
- Appendix 3B
- UPDATE
Follow Arovella Therapeutics into a list and get an email when it puts out news.
Follow Arovella Therapeutics